{"id":"https://openalex.org/W2122499655","doi":null,"title":"Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer.","display_name":"Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer.","publication_year":2012,"publication_date":"2012-02-01","ids":{"openalex":"https://openalex.org/W2122499655","mag":"2122499655","pmid":"https://pubmed.ncbi.nlm.nih.gov/22287751"},"language":"en","primary_location":{"id":"pmid:22287751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22287751","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101587646","display_name":"Takuya Aoki","orcid":"https://orcid.org/0000-0002-1299-4220","observed_orcids":["https://orcid.org/0000-0002-1299-4220"]},"institutions":[{"id":"https://openalex.org/I1314466530","display_name":"Tokai University","ror":"https://ror.org/01p7qe739","country_code":"JP","type":"education","lineage":["https://openalex.org/I1314466530"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuya Aoki","raw_affiliation_strings":["Division of Respiratory Medicine, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. aokitaku@is.icc.u-tokai.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Respiratory Medicine, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. aokitaku@is.icc.u-tokai.ac.jp","institution_ids":["https://openalex.org/I1314466530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021722390","display_name":"Satoshi Igawa","orcid":"https://orcid.org/0000-0002-7527-8766","observed_orcids":["https://orcid.org/0000-0002-7527-8766"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satoshi Igawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078647935","display_name":"Naoki Furuya","orcid":"https://orcid.org/0000-0001-7162-5946","observed_orcids":["https://orcid.org/0000-0001-7162-5946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoki Furuya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077727239","display_name":"Masato Katagiri","orcid":"https://orcid.org/0000-0002-2569-0007","observed_orcids":["https://orcid.org/0000-0002-2569-0007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masato Katagiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035032911","display_name":"Junichirou Hisata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junichirou Hisata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109186247","display_name":"Sakurako Tajiri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakurako Tajiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110485983","display_name":"Naoki Hayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoki Hayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004233738","display_name":"Masamichi Mineshita","orcid":"https://orcid.org/0000-0002-6933-6579","observed_orcids":["https://orcid.org/0000-0002-6933-6579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masamichi Mineshita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036508016","display_name":"Tetsuya Urano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuya Urano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110214172","display_name":"Teruomi Miyazawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teruomi Miyazawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111373805","display_name":"Noriyuki Masuda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noriyuki Masuda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012791965","display_name":"Tadashi Abe","orcid":"https://orcid.org/0000-0003-1074-2350","observed_orcids":["https://orcid.org/0000-0003-1074-2350"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadashi Abe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2247,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.80960614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"2","first_page":"601","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.824999988079071},{"id":"https://openalex.org/keywords/initiation-timing","display_name":"initiation timing","score":0.9169999957084656},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9629999995231628},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.8820000290870667},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8915737867355347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8048828840255737},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6835558414459229},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6700080633163452},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6581280827522278},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5708916783332825},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.47840508818626404},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4164387583732605},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35863929986953735},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08346182107925415},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.07781165838241577},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22287751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22287751","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2122499655","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22287751","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1924428325","https://openalex.org/W1970476748","https://openalex.org/W1971737397","https://openalex.org/W1991140984","https://openalex.org/W2001206698","https://openalex.org/W2005383143","https://openalex.org/W2030132001","https://openalex.org/W2049484790","https://openalex.org/W2062495007","https://openalex.org/W2067005702","https://openalex.org/W2093922887","https://openalex.org/W2095496928","https://openalex.org/W2095618958","https://openalex.org/W2100912832","https://openalex.org/W2105026490","https://openalex.org/W2106787323","https://openalex.org/W2119366998","https://openalex.org/W2120718661","https://openalex.org/W2128082578","https://openalex.org/W2129360604","https://openalex.org/W2129897113","https://openalex.org/W2130652363","https://openalex.org/W2132157071","https://openalex.org/W2136023414","https://openalex.org/W2138297714","https://openalex.org/W2139248078","https://openalex.org/W2139377071","https://openalex.org/W2142464801","https://openalex.org/W2142865455","https://openalex.org/W2153886286","https://openalex.org/W2158179945","https://openalex.org/W2160982674","https://openalex.org/W2165651085","https://openalex.org/W2166084034","https://openalex.org/W2168258970","https://openalex.org/W2404384040","https://openalex.org/W2504684570","https://openalex.org/W2767686444"],"related_works":["https://openalex.org/W2354127646","https://openalex.org/W2140669653","https://openalex.org/W1965754326","https://openalex.org/W3008043757","https://openalex.org/W2382728708","https://openalex.org/W2346455687","https://openalex.org/W2378909579","https://openalex.org/W2970400887","https://openalex.org/W7065717650","https://openalex.org/W367299136"],"abstract_inverted_index":{"AIM:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,128],"analyze":[5],"whether":[6],"or":[7,38],"not":[8,117,132],"the":[9,60,95,120],"efficacy":[10,145],"and":[11,22,63,65,71,74,82,98,100,106,125,140],"safety":[12,147],"of":[13,59],"erlotinib":[14],"are":[15],"influenced":[16],"by":[17],"differences":[18],"among":[19,119],"treatment":[20,138],"lines":[21,139],"initiation":[23,129,141],"timing":[24,130,142],"in":[25,137,148],"advanced":[26,151],"non-small":[27],"cell":[28],"lung":[29],"cancer":[30],"(NSCLC)":[31],"patients.":[32],"PATIENTS":[33],"AND":[34],"METHODS:":[35],"Stage":[36],"III":[37],"IV":[39],"NSCLC":[40],"cases":[41],"were":[42,68,79,103,131],"retrospectively":[43],"evaluated":[44],"at":[45],"three":[46],"university":[47],"hospitals.":[48],"The":[49,90,113,122],"primary":[50],"outcome":[51],"was":[52],"progression-free":[53],"survival":[54],"(PFS).":[55],"RESULTS:":[56],"Median":[57],"PFSs":[58,124],"second-,":[61,96],"third-":[62,97],"fourth-line":[64,99],"over":[66,101],"therapies":[67,102],"138,":[69],"250":[70],"95":[72],"days;":[73],"median":[75,123],"overall":[76],"survivals":[77],"(OSs)":[78],"174,":[80],"260":[81],"270":[83],"days,":[84],"respectively,":[85,108],"with":[86,109,150],"no":[87,110],"significant":[88,111],"differences.":[89,112],"response":[91],"rates":[92],"(RR)":[93],"for":[94],"14%,":[104],"24%":[105],"13%,":[107],"toxicity":[114],"profiles":[115],"did":[116],"differ":[118],"groups.":[121],"OSs":[126],"according":[127],"significantly":[133],"different.":[134],"CONCLUSION:":[135],"Differences":[136],"affected":[143],"neither":[144],"nor":[146],"patients":[149],"NSCLC.":[152]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}